SB
The startup develops gene therapies that target rare genetic disorders, specifically focusing on providing life-long cures for patients with rare bleeding disorders. By utilizing advanced gene editing techniques, the company aims to make these therapies both effective and affordable for those in need.
Updated 3 months ago
Funding
$350K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops gene therapies that target rare genetic disorders, specifically focusing on providing life-long cures for patients with rare bleeding disorders. By utilizing advanced gene editing techniques, the company aims to make these therapies both effective and affordable for those in need.